Among the different therapeutic approaches being explored for treating MS, adult stem cell therapy continues to be one of the most discussed and…
Articles by Maureen Newman
Melatonin, the same hormone that helps people fall asleep by regulating the body’s internal clock, may be helpful in treating…
Two new risk factors for multiple sclerosis have been identified by a research group at the Wellcome Trust Centre for…
A new study testing Amarantus Diagnostics’ MSPrecise on multiple sclerosis patients identified the test as a specific and sensitive diagnostic test for multiple…
Progressive multiple sclerosis patients treated with AB Science’s lead compound AB07002 (masitinib) in a Phase 3 clinical trial showed positive…
Personalized medicine, often applied to treat cancer, may be possible for patients with multiple sclerosis as well. Certain patients respond…
The ability to assess risk may decline as multiple sclerosis disease status progresses over time, as determined by a recent…
Recent attention to the role of mitochondria in the etiology of multiple sclerosis (what causes the disease) suggests that mitochondrial…
A nanometric sensor — an extremely small probe originally designed to test samples for the presence of herbicides, heavy metals,…
RedHill Biopharma Ltd. enrolled the final patient for its Phase IIa, proof-of-concept study testing RHB-104 in…
Neuromyelitis optica (NMO), a rare autoimmune disorder often mistaken for multiple sclerosis, is similar in that it is characterized by myelin…
Exploratory research conducted at Virginia Commonwealth University and the University of Illinois at Chicago may translate into a new therapeutic…
After the Phase 2b clinical trial named Abili-T achieved full enrollment with 190 secondary progress multiple sclerosis…
Throughout the years, Dr. Sarah Thomas and Dr. Peter Thomas at Bournemouth University have been developing a program to aid…
As the most common non-traumatic cause of disability in young people in the industrialized world, multiple sclerosis affects more than…
Considering the range of neurological symptoms normally associated with adult multiple sclerosis (including loss of coordination, weakness, fatigue, and trouble…
A new commentary concerning genetic variability in multiple sclerosis patients highlights a new marker of disease severity. Local IgG…
What do multiple sclerosis and gout have in common? Uric acid. Uric acid, a byproduct of purine metabolism, causes…
Scientists are developing new tools to understand multiple sclerosis pathogenesis and monitor the benefits of treatments. One of these…
One of the most widely disputed treatments for multiple sclerosis is low dose naltrexone (LDN). While a plethora of patient…
What may work better than existing drugs to treat severe multiple sclerosis? Stem cells. A phase 2 clinical study from…
Under development at Innate Immunotherapeutics is a special drug candidate to treat secondary progressive multiple sclerosis (SPMS).
The “2014 Multiple Sclerosis Therapeutic Update,” published in the journal Neurohospitalist by author Bruce Cree,…
Researchers in the laboratory of Steve Goldman, MD, PhD, Co-Director of University of Rochester Center for Translational Neuromedicine, are…
Upper limb spasticity and lower leg cramps and spasms, two conditions that affect patients with multiple sclerosis, are being…
MediciNova, Inc., recently announced that it had surpassed 50% enrollment for the phase 2b clinical trial evaluating MN-166 (ibudilast)…
A vaccination against multiple sclerosis is in progress in the laboratory of SangKon Oh, PhD, at the Baylor Institute…
For the first time, an antisense oligonucleotide has been shown to be effective in treating relapse-remitting multiple sclerosis.
Phase 3 clinical trial results from Biogen Idec and AbbVie presented at the Sixth Triennial Joint Meeting…
Trying to nail down the reason for executive deficits in multiple sclerosis can be difficult, considering the number of…